Home > List All Publishers > Cutting Edge Information

Cutting Edge Information

Pharmaceutical research intelligence firm Cutting Edge Information, was founded in 2002 by Jason Richardson (Chief Executive Officer) and Adam Bianchi (Chief Operating Officer). The company is located in Durham, North Carolina, and offers customized consulting and a growing library of targeted and insightful pharmaceutical research reports. Cutting Edge Information delivers an innovative new approach to distributing comprehensive pharmaceutical and biotechnology benchmarking data. CEI offers objective, comprehensive primary and secondary research on critical industry issues as well as customized consulting services.

List of reports from Cutting Edge Information

Pharmaceutical Mobile Health: Transforming Brand Marketing, Healthcare Communication and Patient Adherence 11/1/2012 \| published by: Cutting Edge Information ... wider than ever — and mobile use is projected to grow significantly. To leverage that potential, life science companies launch mHealth initiatives that combine thoughtful strategic planning, strong stakeholder support and objectives that align mobile ... \| more...	$7,695.00
Pharmaceutical Launch Sequencing: Mapping Commercialization Opportunities to Maximize Global Value and Expand Market Access 9/1/2012 \| published by: Cutting Edge Information ... lower revenue potential worldwide. To maximize product revenue, especially for innovative drugs, companies must carefully prioritize the order in which different markets receive their products. Global launch sequencing is a complex task requiring input from ... \| more...	$7,695.00
Managing MSLs in a Global Medical Organization: Budget, Staffing and Compensation Benchmarks 7/1/2012 \| published by: Cutting Edge Information ... In addition to thought leader management, MSLs now support a number of internal clients as they take on market access and emerging healthcare issues. These trends lead MSLs in exciting new directions — but they ... \| more...	$7,695.00
MSL Activities and Performance Measurement: Harnessing KOL Relationships for Optimal Clinical Support 7/1/2012 \| published by: Cutting Edge Information ... commercial support. As MSLs adjust to their increased responsibilities and influence, they must streamline activities while proving value to upper management. This report addresses those two areas by providing in-depth benchmarks for global organizations seeking ... \| more...	$7,695.00
Pharmaceutical Market Research Groups: Creating Knowledge for Better Brand Decisions 6/1/2012 \| published by: Cutting Edge Information ... the economy stabilizes, these groups are positioned to both grow in influence and to deliver unique decision support throughout their organizations. Teams that succeed in these efforts build strong cross-functional ties and proactively address the ... \| more...	$7,695.00
Medical Information Teams And Call Center Management 6/1/2012 \| published by: Cutting Edge Information ... vary from medical professionals to patients — not to mention internal clients and stakeholders. While effective medical information teams embrace patient-centric attitudes, these teams must also work to increase their visibility within the pharmaceutical company. ... \| more...	$7,695.00
Health Economics and Outcomes Research: Aligning Clinical and Commercial to Meet Payer Demands and Win Reimbursement 5/1/2012 \| published by: Cutting Edge Information ... pricing and pharmacoeconomics to navigate the challenges associated with lower reimbursement rates. The process starts with the health economics and outcomes research (HEOR) team. Health economics work fuels market access, and HEOR’s prominence increases as ... \| more...	$7,695.00
Pharmaceutical Compliance Best Practices: Ensuring Quality through Documentation, Training and Auditing 5/1/2012 \| published by: Cutting Edge Information ... R&D to the very end of the product lifecycle. Compliance teams do critically important work across a wide range of functions, but they face a raft of challenges. Simply keeping pace with the dizzying, ever-growing ... \| more...	$7,695.00
Launching Pharmaceutical Brands: Formulas for Commercialization Success 4/1/2012 \| published by: Cutting Edge Information ... market access to medical affairs, is more complex than ever. No two companies approach this marketing puzzle in the same way. Lacking a crystal ball, brand teams and their allies invest millions of dollars to ... \| more...	$7,695.00
Regulatory Affairs: Safeguarding Submission Success and Product Development Strategy 4/1/2012 \| published by: Cutting Edge Information ... regulatory teams enable organizations to navigate an increasingly complex, global healthcare landscape. As the responsibilities of regulatory affairs groups evolve, and these teams move closer to the C-suite, companies provide them with significant budgets even ... \| more...	$7,695.00
U.S. Managed Markets: Driving Commercial Success through Outcomes-Based Reimbursement 3/1/2012 \| published by: Cutting Edge Information ... effectiveness research and value-based pricing floating across the Atlantic, payers dissect new products from every angle. US managed markets teams must prove value in language unique to each payer. To accomplish this task, they anticipate ... \| more...	$7,695.00
Patient Adherence and Compliance: Improving Outcomes through Patient Engagement Programs 3/1/2012 \| published by: Cutting Edge Information ... in driving desired outcomes. In answer, companies show new determination to create patient-centric initiatives that will supplant the traditional, formulaic approaches of the past. Dedicated patient engagement teams are rising in prominence, and programs focused ... \| more...	$7,695.00
Companion Diagnostics and Biomarker Development: Partnership Strategies and Benchmarks 2/1/2012 \| published by: Cutting Edge Information ... the ability to target specific patient populations — unleashing the potential for greater efficacy, accelerated regulatory approval and better reimbursement. Clarify your decision making with this report’s in-depth data benchmarks and best practices from leading ... \| more...	$7,695.00
Pharmaceutical Portfolio Management Selecting Targets, Filling Pipelines and Preparing for Post-Launch Success 1/1/2012 \| published by: Cutting Edge Information ... impact company fortunes — especially when advancing the right compounds creates the potential for billions of dollars in long-term revenue. Effective portfolio management requires foresight and preparation, a challenge given the daily pressures faced by ... \| more...	$7,695.00
Strategic Medical Publications Management: Plan Development and Resource Benchmarks 1/1/2012 \| published by: Cutting Edge Information ... product education. A cornerstone of medical communications strategy, publications groups engage with functions across the company, as well as with vendors, during the manuscript-creation process. Despite the team’s critical importance, proving value to upper management ... \| more...	$7,695.00
Pharmaceutical Digital Marketing and Social Media 11/1/2011 \| published by: Cutting Edge Information ... digital activity, and growth trends indicate that some digital channels will surpass more traditional media tools. But as the industry explores this new territory, questions loom about regulatory compliance, ROI, adverse events monitoring and other ... \| more...	$7,695.00
Health Outcomes Liaisons: Managing a Field-Based Team that Speaks the Payer’s Language 10/1/2011 \| published by: Cutting Edge Information ... with payers and secure the best reimbursement, companies increasingly deploy health outcomes liaisons (HOLs). HOLs forge connections with key target audiences by communicating critical health economics and outcomes research (HEOR) data. Trailblazing companies have assembled ... \| more...	$7,695.00
KOL Fair-Market Value and Aggregate Spend 10/1/2011 \| published by: Cutting Edge Information ... of the Sunshine Act is already being felt as pharmaceutical, biotechnology and medical device companies invest millions of dollars to implement aggregate spend tracking systems. These systems are critical components in remaining compliant and meeting ... \| more...	$7,695.00
Investigator Initiated Trial Management 9/1/2011 \| published by: Cutting Edge Information ... publication in a medical journal to advance a drug’s — and the company’s — profile and credibility. Supported by dedicated resources, effective IIT teams reach that point by navigating process delays while maintaining regulatory compliance ... \| more...	$7,695.00
Succession Planning: Preparing Tomorrow’s Leaders 9/1/2011 \| published by: Cutting Edge Information ... a plan or do not update it regularly - leaving them vulnerable and unprepared for change. Part of ongoing excellence, however, is resilience. Forward-looking companies see succession planning as an opportunity to reinforce corporate identity, ... \| more...	$995.00
Market Access Management: Building Teams that Deliver Value to Payers 8/1/2011 \| published by: Cutting Edge Information ... these teams must harness resources and advance objectives across an incredible network of stakeholders - everyone from internal subfunctions to other major departments to external customers both private and public. In short, market access groups ... \| more...	$7,695.00
Phase IV Clinical Trials 7/1/2011 \| published by: Cutting Edge Information ... IV studies are a growing necessity — but they often remain deprioritized and under-resourced as teams struggle to marshal needed support for both strategy and execution. Use this study to reinforce Phase IV research and ... \| more...	$7,695.00
Pharmaceutical Business Development and Licensing 6/1/2011 \| published by: Cutting Edge Information ... for example, as well as patent expirations, pipeline setbacks and other challenges. Smaller organizations may have wizards in the lab — but limited infrastructure and resources to commercialize their innovations. Superior business development teams address ... \| more...	$7,695.00
Pharmaceutical Marketing Strategy: Key ROI Benchmarks to Drive Brand Success 5/1/2011 \| published by: Cutting Edge Information ... — and they prioritize elements in their marketing mixes based on the impact of each activity, channel or promotional tool. Discover how 28 top pharmaceutical and biotech teams have built their products’ marketing plans, then ... \| more...	$7,695.00
Pharmaceutical Pricing Strategy 4/1/2011 \| published by: Cutting Edge Information ... Discover how leading life sciences companies find and justify prices in light of heightened pressures from government payers and stringent economic policies. Explore in-depth benchmarks and insights, culled from over 30 pharmaceutical, biotechnology, and medical ... \| more...	$7,695.00

< prev 1 2 3 next >

Cutting Edge Information

List of reports from Cutting Edge Information

Research assistance

Join Alert Me now!